Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome

Nature volume 471, pages 230–234 (2011)Cite this article

Abstract

Individuals with congenital or acquired prolongation of the QT interval, or long QT syndrome (LQTS), are at risk of life-threatening ventricular arrhythmia1,2. LQTS is commonly genetic in origin but can also be caused or exacerbated by environmental factors1,3. A missense mutation in the L-type calcium channel CaV1.2 leads to LQTS in patients with Timothy syndrome4,5. To explore the effect of the Timothy syndrome mutation on the electrical activity and contraction of human cardiomyocytes, we reprogrammed human skin cells from Timothy syndrome patients to generate induced pluripotent stem cells, and differentiated these cells into cardiomyocytes. Electrophysiological recording and calcium (Ca2+) imaging studies of these cells revealed irregular contraction, excess Ca2+ influx, prolonged action potentials, irregular electrical activity and abnormal calcium transients in ventricular-like cells. We found that roscovitine, a compound that increases the voltage-dependent inactivation of CaV1.2 (refs 6–8), restored the electrical and Ca2+ signalling properties of cardiomyocytes from Timothy syndrome patients. This study provides new opportunities for studying the molecular and cellular mechanisms of cardiac arrhythmias in humans, and provides a robust assay for developing new drugs to treat these diseases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Generation of cardiomyocytes from control and Timothy syndrome iPSCs.
Figure 2: Electrophysiological features of Timothy syndrome cardiomyocytes.
Figure 3: Ca 2+ signalling in Timothy syndrome and control cardiomyocytes.
Figure 4: Roscovitine rescues the cellular phenotypes of Timothy syndrome cardiomyocytes.

Similar content being viewed by others

References

  1. Keating, M. T. The long QT syndrome. A review of recent molecular genetic and physiologic discoveries. Medicine 75, 1–5 (1996)

    Article  CAS  Google Scholar 

  2. Huikuri, H. V., Castellanos, A. & Myerburg, R. J. Sudden death due to cardiac arrhythmias. N. Engl. J. Med. 345, 1473–1482 (2001)

    Article  CAS  Google Scholar 

  3. Paakkari, I. Cardiotoxicity of new antihistamines and cisapride. Toxicol. Lett. 127, 279–284 (2002)

    Article  CAS  Google Scholar 

  4. Splawski, I. et al. CaV1.2 Ca2+ channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19–31 (2004)

    Article  CAS  Google Scholar 

  5. Splawski, I. et al. Severe arrhythmia disorder caused by cardiac L-type Ca2+ channel mutations. Proc. Natl Acad. Sci. USA 102, 8089–8096 (2005)

    Article  ADS  CAS  Google Scholar 

  6. Yarotskyy, V. & Elmslie, K. S. Roscovitine, a cyclin-dependent kinase inhibitor, affects several gating mechanisms to inhibit cardiac L-type (CaV1.2) Ca2+ channels. Br. J. Pharmacol. 152, 386–395 (2007)

    Article  CAS  Google Scholar 

  7. Yarotskyy, V., Gao, G., Peterson, B. Z. & Elmslie, K. S. The Timothy syndrome mutation of cardiac CaV1.2 (L-type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivation. J. Physiol. (Lond.) 587, 551–565 (2009)

    Article  CAS  Google Scholar 

  8. Yarotskyy, V. et al. Roscovitine binds to novel L-channel (CaV1.2) sites that separately affect activation and inactivation. J. Biol. Chem. 285, 43–53 (2010)

    Article  CAS  Google Scholar 

  9. Roden, D. M. & Viswanathan, P. C. Genetics of acquired long QT syndrome. J. Clin. Invest. 115, 2025–2032 (2005)

    Article  CAS  Google Scholar 

  10. Chen, L. et al. Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc. Natl Acad. Sci. USA 104, 20990–20995 (2007)

    Article  ADS  CAS  Google Scholar 

  11. Roden, D. M. Clinical practice. Long-QT syndrome. N. Engl. J. Med. 358, 169–176 (2008)

    Article  CAS  Google Scholar 

  12. Moretti, A. et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397–1409 (2010)

    Article  CAS  Google Scholar 

  13. Reuter, H. Ion channels in cardiac cell membranes. Annu. Rev. Physiol. 46, 473–484 (1984)

    Article  CAS  Google Scholar 

  14. Flucher, B. E. & Franzini-Armstrong, C. Formation of junctions involved in excitation-contraction coupling in skeletal and cardiac muscle. Proc. Natl Acad. Sci. USA 93, 8101–8106 (1996)

    Article  ADS  CAS  Google Scholar 

  15. Seisenberger, C. et al. Functional embryonic cardiomyocytes after disruption of the L-type α1C (Cav1.2) Ca2+ channel gene in the mouse. J. Biol. Chem. 275, 39193–39199 (2000)

    Article  CAS  Google Scholar 

  16. Takeshima, H. et al. Embryonic lethality and abnormal cardiac myocytes in mice lacking ryanodine receptor type 2. EMBO J. 17, 3309–3316 (1998)

    Article  CAS  Google Scholar 

  17. Yazawa, M. et al. TRIC channels are essential for Ca2+ handling in intracellular stores. Nature 448, 78–82 (2007)

    Article  ADS  CAS  Google Scholar 

  18. Barrett, C. F. & Tsien, R. W. The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV1.2 L-type Ca2+ channels. Proc. Natl Acad. Sci. USA 105, 2157–2162 (2008)

    Article  ADS  CAS  Google Scholar 

  19. Thiel, W. H. et al. Proarrhythmic defects in Timothy syndrome require calmodulin kinase II. Circulation 118, 2225–2234 (2008)

    Article  CAS  Google Scholar 

  20. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007)

    Article  CAS  Google Scholar 

  21. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007)

    Article  ADS  CAS  Google Scholar 

  22. Aoi, T. et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321, 699–702 (2008)

    Article  ADS  CAS  Google Scholar 

  23. He, J. Q., Ma, Y., Lee, Y., Thomson, J. A. & Kamp, T. J. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ. Res. 93, 32–39 (2003)

    Article  CAS  Google Scholar 

  24. Zhang, J. et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104, e30–e41 (2009)

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Brunner, M. et al. Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. J. Clin. Invest. 118, 2246–2259 (2008)

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Meijer, L. et al. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243, 527–536 (1997)

    Article  CAS  Google Scholar 

  27. Tran, T. H. et al. Wnt3a-induced mesoderm formation and cardiomyogenesis in human embryonic stem cells. Stem Cells 27, 1869–1878 (2009)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank K. Timothy and the Timothy syndrome patients who participated in this study; U. Francke for discussion and for providing karyotyping expertise; A. Cherry and D. Bangs for fibroblast isolation; K. C. Chan for iPSC cultures; O. Shcheglovitov for help with electrophysiological recordings; and A. Olson for help with the confocal microscope. Funding was provided by grants from the Japan Society for the Promotion for Science and the American Heart Association Western States to M.Y., and a National Institutes of Health Director’s Pioneer Award, a grant from the Simons Foundation to R.E.D and gifts from L. Miller, B. and F. Horowitz and M. McCaffery.

Author information

Author notes

  1. Brian Hsueh, Xiaolin Jia & Anca M. Pasca

    Present address: Present addresses: Department of Chemistry, Princeton University, Princeton, New Jersey 08544, USA (B.H.); Baylor College of Medicine, Houston, Texas 77030, USA (X.J.); Lucile Packard Children's Hospital, Stanford University, Palo Alto, California 94304, USA (A.M.P.).,

Authors and Affiliations

  1. Department of Neurobiology, Stanford University School of Medicine, Stanford, 94305, California, USA

    Masayuki Yazawa, Brian Hsueh, Xiaolin Jia, Anca M. Pasca & Ricardo E. Dolmetsch

  2. Department of Pediatrics, Stanford University School of Medicine, Stanford, 94305, California, USA

    Jonathan A. Bernstein

  3. Department of Psychiatry & Behavioral Science, Stanford University School of Medicine, Stanford, 94305, California, USA

    Joachim Hallmayer

Authors
  1. Masayuki Yazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian Hsueh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaolin Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anca M. Pasca
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jonathan A. Bernstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joachim Hallmayer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ricardo E. Dolmetsch
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

M.Y. and R.E.D. designed research and wrote the manuscript; J.A.B., J.H. and R.E.D recruited the Timothy syndrome patients; M.Y. and X.J. generated and characterized control and Timothy syndrome iPSCs; A.M.P. conducted karyotyping; M.Y. performed generation and characterization of human cardiomyocytes, whole-cell patch clamp, and Ca2+ imaging; M.Y. and B.H. analysed cardiomyocytes contraction rates.

Corresponding author

Correspondence to Ricardo E. Dolmetsch.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Information

This file contains Supplementary Figures 1-8 with legends and Supplementary Tables 1-2. (PDF 1874 kb)

Supplementary Methods

This file contains Supplementary Materials and Methods. (PDF 149 kb)

Supplementary Movie 1

This movie shows control EBs (round) spontaneously contracting at d37. (MOV 9615 kb)

Supplementary Movie 2

This movie shows control EBs (flat) spontaneously contracting at d37. (MOV 9497 kb)

Supplementary Movie 3

This movie shows TS EBs (round) spontaneously contracting at d37. (MOV 10200 kb)

Supplementary Movie 4

This movie shows TS EBs (flat) spontaneously contracting at d37. (MOV 9497 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yazawa, M., Hsueh, B., Jia, X. et al. Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 471, 230–234 (2011). https://doi.org/10.1038/nature09855

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature09855

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing